Jillian G. Baker
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
Journal: British journal of pharmacology
Published: December 29, 2025
Comparing the Molecular Pharmacological Properties of Existing β-Blockers to Determine the Theoretically Most "Ideal" Anti-Cancer β-Blocker.
Journal: Pharmacology research & perspectives
Published: October 20, 2025
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β2-Agonists Used for Asthma and COPD.
Journal: Pharmacology research & perspectives
Published: May 28, 2025
Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is Needed.
Journal: Function (Oxford, England)
Published: October 20, 2024
Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.
Journal: Handbook of experimental pharmacology
Published: June 26, 2024
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Journal: British journal of pharmacology
Published: December 20, 2023
Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.
Journal: Handbook of experimental pharmacology
Published: September 14, 2023
Rational design, synthesis, and pharmacological evaluation of a cohort of novel beta-adrenergic receptors ligands enables an assessment of structure-activity relationships.
Journal: European journal of medicinal chemistry
Published: October 05, 2022
The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Journal: Pharmacology research & perspectives
Published: June 28, 2022
The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human β1-Adrenoceptor.
Journal: Molecular pharmacology
Published: June 28, 2022
The affinity and selectivity of α-adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Journal: Pharmacology research & perspectives
Published: November 26, 2021
Last Updated: 09/26/2026